Guanidine Degradation Enzyme and Methods of Use

Research output: Patent

Abstract

Presented herein are Synechococcus strains engineered to express the bacterial ethylene-forming enzyme (EFE) that exhibit unstable ethylene production due to toxicity and genomic instability induced by accumulation of the EFE-byproduct guanidine. Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production. The engineered strains and methods disclosed herein are useful for guanidine degradation pathways and for ethylene bioproduction in cyanobacteria.
Original languageAmerican English
Patent number12,448,632 B2
Filing date21/10/25
StatePublished - 2025

NLR Publication Number

  • NREL/PT-2700-98200

Keywords

  • ethylene-forming enzyme (EFE)
  • genomic instability
  • Synechococcus strains

Fingerprint

Dive into the research topics of 'Guanidine Degradation Enzyme and Methods of Use'. Together they form a unique fingerprint.

Cite this